Unfortunately for some shareholders, the Canopy Growth Corporation (TSE:WEED) share price has dived 28% in the last thirty days, prolonging recent pain. The recent drop completes a disastrous twelve months for shareholders, who are sitting on a 86% loss during that time.
In spite of the heavy fall in price, there still wouldn’t be many who think Canopy Growth’s price-to-sales (or “P/S”) ratio of 1.1x is worth a mention when it essentially matches the median P/S in Canada’s Pharmaceuticals industry. Although, it’s not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
Check out our latest analysis for Canopy Growth
How Has Canopy Growth Performed Recently?
While the industry has experienced revenue growth lately, Canopy Growth’s revenue has gone into reverse gear, which is not great. …
